125 related articles for article (PubMed ID: 38865630)
1. Effectiveness of rifaximin and probiotics for the correction of intestinal permeability in patients with metabolic-associated fatty liver disease in combination with type 2 diabetes mellitus.
Didyk OK; Chernyavskyi VV; Shypulin VP; Tishchenko VV
Wiad Lek; 2024; 77(4):732-738. PubMed ID: 38865630
[TBL] [Abstract][Full Text] [Related]
2. The impact of probiotics and n-3 long-chain polyunsaturated fatty acids on intestinal permeability in pregnancy: a randomised clinical trial.
Mokkala K; Pussinen P; Houttu N; Koivuniemi E; Vahlberg T; Laitinen K
Benef Microbes; 2018 Feb; 9(2):199-208. PubMed ID: 29345158
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of rifaximin on circulating endotoxins and cytokines in patients with nonalcoholic fatty liver disease.
Gangarapu V; Ince AT; Baysal B; Kayar Y; Kılıç U; Gök Ö; Uysal Ö; Şenturk H
Eur J Gastroenterol Hepatol; 2015 Jul; 27(7):840-5. PubMed ID: 26043290
[TBL] [Abstract][Full Text] [Related]
4. Targeting the Intestinal Microbiota to Prevent Type 2 Diabetes and Enhance the Effect of Metformin on Glycaemia: A Randomised Controlled Pilot Study.
Palacios T; Vitetta L; Coulson S; Madigan CD; Lam YY; Manuel R; Briskey D; Hendy C; Kim JN; Ishoey T; Soto-Giron MJ; Schott EM; Toledo G; Caterson ID
Nutrients; 2020 Jul; 12(7):. PubMed ID: 32660025
[TBL] [Abstract][Full Text] [Related]
5. The Effect of Probiotics (MCP
Mohamad Nor MH; Ayob N; Mokhtar NM; Raja Ali RA; Tan GC; Wong Z; Shafiee NH; Wong YP; Mustangin M; Nawawi KNM
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579068
[TBL] [Abstract][Full Text] [Related]
6. Positive regulatory effects of perioperative probiotic treatment on postoperative liver complications after colorectal liver metastases surgery: a double-center and double-blind randomized clinical trial.
Liu Z; Li C; Huang M; Tong C; Zhang X; Wang L; Peng H; Lan P; Zhang P; Huang N; Peng J; Wu X; Luo Y; Qin H; Kang L; Wang J
BMC Gastroenterol; 2015 Mar; 15():34. PubMed ID: 25881090
[TBL] [Abstract][Full Text] [Related]
7. Effects of Probiotic Strains on Disease Activity and Enteric Permeability in Psoriatic Arthritis-A Pilot Open-Label Study.
Haidmayer A; Bosch P; Lackner A; D'Orazio M; Fessler J; Stradner MH
Nutrients; 2020 Aug; 12(8):. PubMed ID: 32764250
[TBL] [Abstract][Full Text] [Related]
8. Serum zonulin levels in type 2 diabetes patients with diabetic kidney disease.
Sirin FB; Korkmaz H; Eroglu I; Afsar B; Kumbul Doguc D
Endokrynol Pol; 2021; 72(5):545-549. PubMed ID: 34057189
[TBL] [Abstract][Full Text] [Related]
9. The efficacy and the immunomodulatory effect of rifaximin in prophylaxis of spontaneous bacterial peritonitis in cirrhotic Egyptian patients.
Mostafa T; Badra G; Abdallah M
Turk J Gastroenterol; 2015 Mar; 26(2):163-9. PubMed ID: 25835116
[TBL] [Abstract][Full Text] [Related]
10. Serum zonulin is elevated in IBS and correlates with stool frequency in IBS-D.
Singh P; Silvester J; Chen X; Xu H; Sawhney V; Rangan V; Iturrino J; Nee J; Duerksen DR; Lembo A
United European Gastroenterol J; 2019 Jun; 7(5):709-715. PubMed ID: 31210949
[TBL] [Abstract][Full Text] [Related]
11. Effect of probiotic or prebiotic supplementation on antibiotic therapy in the small intestinal bacterial overgrowth: a comparative evaluation.
Rosania R; Giorgio F; Principi M; Amoruso A; Monno R; Di Leo A; Ierardi E
Curr Clin Pharmacol; 2013 May; 8(2):169-72. PubMed ID: 23244247
[TBL] [Abstract][Full Text] [Related]
12. Could serum zonulin be an intestinal permeability marker in diabetes kidney disease?
Carpes LS; Nicoletto BB; Canani LH; Rheinhemer J; Crispim D; Souza GC
PLoS One; 2021; 16(6):e0253501. PubMed ID: 34170951
[TBL] [Abstract][Full Text] [Related]
13. The effects of perioperative probiotic treatment on serum zonulin concentration and subsequent postoperative infectious complications after colorectal cancer surgery: a double-center and double-blind randomized clinical trial.
Liu ZH; Huang MJ; Zhang XW; Wang L; Huang NQ; Peng H; Lan P; Peng JS; Yang Z; Xia Y; Liu WJ; Yang J; Qin HL; Wang JP
Am J Clin Nutr; 2013 Jan; 97(1):117-26. PubMed ID: 23235200
[TBL] [Abstract][Full Text] [Related]
14. A polyphenol-rich dietary pattern improves intestinal permeability, evaluated as serum zonulin levels, in older subjects: The MaPLE randomised controlled trial.
Del Bo' C; Bernardi S; Cherubini A; Porrini M; Gargari G; Hidalgo-Liberona N; González-Domínguez R; Zamora-Ros R; Peron G; Marino M; Gigliotti L; Winterbone MS; Kirkup B; Kroon PA; Andres-Lacueva C; Guglielmetti S; Riso P
Clin Nutr; 2021 May; 40(5):3006-3018. PubMed ID: 33388204
[TBL] [Abstract][Full Text] [Related]
15. Impaired intestinal barrier function in type 2 diabetic patients measured by serum LPS, Zonulin, and IFABP.
Yuan JH; Xie QS; Chen GC; Huang CL; Yu T; Chen QK; Li JY
J Diabetes Complications; 2021 Feb; 35(2):107766. PubMed ID: 33168395
[TBL] [Abstract][Full Text] [Related]
16. Rifaximin in nonalcoholic fatty liver disease: hit multiple targets with a single shot.
Abdel-Razik A; Mousa N; Shabana W; Refaey M; Elzehery R; Elhelaly R; Zalata K; Abdelsalam M; Eldeeb AA; Awad M; Elgamal A; Attia A; El-Wakeel N; Eldars W
Eur J Gastroenterol Hepatol; 2018 Oct; 30(10):1237-1246. PubMed ID: 30096092
[TBL] [Abstract][Full Text] [Related]
17. The effects of a multispecies probiotic on migraine and markers of intestinal permeability-results of a randomized placebo-controlled study.
de Roos NM; van Hemert S; Rovers JMP; Smits MG; Witteman BJM
Eur J Clin Nutr; 2017 Dec; 71(12):1455-1462. PubMed ID: 28537581
[TBL] [Abstract][Full Text] [Related]
18. Rifaximin alters intestinal bacteria and prevents stress-induced gut inflammation and visceral hyperalgesia in rats.
Xu D; Gao J; Gillilland M; Wu X; Song I; Kao JY; Owyang C
Gastroenterology; 2014 Feb; 146(2):484-96.e4. PubMed ID: 24161699
[TBL] [Abstract][Full Text] [Related]
19. Gut permeability is related to body weight, fatty liver disease, and insulin resistance in obese individuals undergoing weight reduction.
Damms-Machado A; Louis S; Schnitzer A; Volynets V; Rings A; Basrai M; Bischoff SC
Am J Clin Nutr; 2017 Jan; 105(1):127-135. PubMed ID: 28049662
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor 1 as a possible target in non-alcoholic fatty liver disease.
Baumann A; Nier A; Hernández-Arriaga A; Brandt A; Lorenzo Pisarello MJ; Jin CJ; Pilar E; Camarinha-Silva A; Schattenberg JM; Bergheim I
Sci Rep; 2021 Sep; 11(1):17815. PubMed ID: 34497333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
